US 11713315
5 to 7 membered heterocyclic amides as JAK inhibitors
granted A61KA61K9/0073A61P
Quick answer
US patent 11713315 (5 to 7 membered heterocyclic amides as JAK inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K9/0073, A61P, A61P11/00, A61P11/06